Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2025, Vol. 30 ›› Issue (9): 1253-1259.doi: 10.12092/j.issn.1009-2501.2025.09.012

Previous Articles     Next Articles

Research progress on the interaction between epithelial cells and macrophages in lung diseases

LI Mengyu1,2, JIANG Wei2, ZHANG Yafei2, PAN Xin2, WANG Yuanyuan2,1   

  1. 1School of Pharmacy, Anhui Medical University, Hefei 230032, Anhui, China; 2Department of Pharmacy, the Second Affiliated Hospital of Anhui Medical University, Hefei 230601, Anhui, China
  • Received:2024-01-29 Revised:2024-03-13 Online:2025-09-26 Published:2025-09-09

Abstract:

The interaction between epithelial cells and macrophages plays a crucial role in the progression of lung diseases, including immune defense, inflammation regulation, tissue repair, and regeneration. However, an imbalance in this interaction can contribute to the development of various lung diseases. In idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease, and lung cancer, macrophages can promote disease progression by secreting cytokines that act on epithelial cells. Simultaneously, activated epithelial cells release cytokines to recruit and activate more macrophages in a positive feedback loop. Thus, comprehensive studies of the interactions between epithelial cells and macrophages in various lung diseases have the potential to identify new therapeutic targets and develop innovative strategies for disease management. This review aims to summarize the current knowledge regarding the interaction between epithelial cells and macrophages in idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease, and lung cancer, with the goal of inspiring new research directions for the treatment of lung diseases.

Key words: epithelial cell, macrophage, interaction, idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease, lung cancer

CLC Number: